Apple bought back three times more share than expected.
Breaking News
Microsoft's virtual assistant will be reworked in preparation for future release.
The "best" Apple Q3 2013 analysts had "inspired" estimates, but not all "hit every nail on the head."
Apple shares experienced what was probably its best day ever in 2013.
The pressure is on for Apple to launch new products.
Latest figures for Apple were released recently.
Apple's big sales boosted shares of its Asian suppliers.
Apple's chief executive officer Tim Cook said in an earnings call that the company will definitely do something for the automobile.
Several analysts gave product-centered comments of Apple's June quarter results.
Samsung announced the launch of their new tablet product in the highly contested Indian tech consumer market.
According to analysts, Apple and Samsung might strike a deal to stop the ongoing smartphone patent wars between the two tech titans.
Analysts commented on their take on Apple's June quarter results.
Despite gaining GPB6 billion in the United Kingdom, Apple allegedly paid only GBP10 million in UK corporation taxes.
‘Tiger cub’ Laffont was bullish on content but not Apple.
Analysts said that Apple's September quarter forecast would give hints at next iPhone's release date.
Subscribe to VCpost newsletter
Most Popular
- Neuralink Co-Founder Implies He Left Elon Musk's Brain Implant Company Over Safety Concerns
- Tennessee Cleaning Company Fined $650,000 for Illegally Hiring Children, Some as Young as 13, to Clean Dangerous Slaughterhouses
- New York Is the World's Richest City, With Its Millionaires and Billionaires' Wealth Greater Than GDPs of Brazil, Canada, Italy
- Mini Gold Bars Are Causing a Frenzy in South Korea as Buyers Rush to Get Them in Convenience Stores, Vending Machines
- AstraZeneca to Pull Out COVID-19 Vaccine Worldwide After Adverse Side Effect Admission
- Joe Biden Administration Sanctions Colombian Maritime Companies Preying on Vulnerable Migrants Seeking to Enter US
- Pfizer Settles 10,000 Zantac Heartburn Medication Lawsuits Over Cancer Risks
- Amgen Challenges Novo Nordisk, Eli Lilly in Weight Loss Drug Market as Investors Flock for Next Obesity Drug Payout
